De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Globus Medical Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Globus Medical heeft een totaal eigen vermogen van $4.0B en een totale schuld van $430.5M, wat de schuld-eigenvermogensverhouding op 10.8% brengt. De totale activa en totale passiva bedragen respectievelijk $5.0B en $1.0B. De EBIT Globus Medical is $352.5M waardoor de rentedekking -317.5 is. Het heeft contanten en kortetermijnbeleggingen van $492.9M.
Belangrijke informatie
10.8%
Verhouding schuld/eigen vermogen
US$430.49m
Schuld
| Rente dekkingsratio | -317.5x |
| Contant | US$492.93m |
| Aandelen | US$3.98b |
| Totaal verplichtingen | US$1.02b |
| Totaal activa | US$4.99b |
Recente financiële gezondheidsupdates
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Recent updates
Globus Medical: A Post Acquisition Analysis
Aug 26Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors
Jun 28An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Apr 08Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Feb 27Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
Feb 09Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings
Jan 17Globus Medical: Merger Overhang Lingering
Nov 27Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?
Oct 27Globus Medical: Almost Having My Back
Sep 13Globus Medical: Slightly Too Pricey Right Now
Aug 07Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Jul 18Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jul 11Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching
Jun 18Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Apr 09What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?
Mar 22Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?
Feb 24Globus Medical Q4 2022 Earnings Preview
Feb 20Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line
Nov 08A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Oct 15Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
Sep 02Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Sep 02Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?
Aug 11Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective
Jun 05Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital
May 24Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
May 06Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.9B ) GMED } overtreffen de korte termijn passiva ( $794.1M ).
Langlopende schulden: De kortetermijnactiva GMED ( $1.9B ) overtreffen de langetermijnschulden ( $223.3M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: GMED heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van GMED is de afgelopen 5 jaar gestegen van 0% naar 10.8%.
Schuldendekking: De schuld van GMED wordt goed gedekt door de operationele kasstroom ( 60.8% ).
Rentedekking: GMED verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.